Skip to main content

Table 2 Comparison of baseline and post-treatment SUV in both responder and non-responder groups

From: Role of PET/CT in post-therapeutic assessment of bronchogenic carcinoma

  Responder group (n = 8) Non-responder group (n = 12)
Pre-treatment Post-treatment P-value Pre-treatment Post-treatment P-value
SUV
 Median 14.6 5.6   10.9 11.8  
 IQR 11.8–17.7 2.8–6.3 0.008 4.95–20.7 6.3–19.4  0.638
 Range 10–20 0–8   3.5–34.7 2–28.2  
  1. IQR interquartile range, n number